{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:21:03Z","timestamp":1790716863401,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2020JJ5995"],"award-info":[{"award-number":["2020JJ5995"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.lfs.2020.118009","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T15:07:27Z","timestamp":1593270447000},"page":"118009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["3-Bromopyruvate ameliorates pulmonary arterial hypertension by improving mitochondrial metabolism"],"prefix":"10.1016","volume":"256","author":[{"given":"Yuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118009_bb0005","doi-asserted-by":"crossref","first-page":"j5492","DOI":"10.1136\/bmj.j5492","article-title":"Pulmonary arterial hypertension: pathogenesis and clinical management","volume":"360","author":"Thenappan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.lfs.2020.118009_bb0010","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/CIRCULATIONAHA.117.029254","article-title":"Prognostic value of follow-up hemodynamic variables after initial management in pulmonary arterial hypertension","volume":"137","author":"Weatherald","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.118009_bb0015","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.115.018435","article-title":"Effect of warfarin treatment on survival of patients with pulmonary arterial hypertension (PAH) in the registry to evaluate early and long-term PAH disease management (REVEAL)","volume":"132","author":"Preston","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.118009_bb0020","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1378\/chest.15-0300","article-title":"Five-year outcomes of patients enrolled in the REVEAL registry","volume":"148","author":"Farber","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2020.118009_bb0025","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.117.031655","article-title":"Pyruvate kinase and Warburg metabolism in pulmonary arterial hypertension: uncoupled glycolysis and the cancer-like phenotype of pulmonary arterial hypertension","volume":"136","author":"Archer","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.118009_bb0030","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3390\/molecules21121730","article-title":"The HK2 dependent \u201cWarburg effect\u201d and mitochondrial oxidative phosphorylation in cancer: targets for effective therapy with 3-bromopyruvate","volume":"21","author":"Lis","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2020.118009_bb0035","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1172\/JCI120847","article-title":"Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains","volume":"128","author":"Culley","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.118009_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1164\/rccm.201708-1751OC","article-title":"Mitochondrial HSP90 accumulation promotes vascular remodeling in pulmonary arterial hypertension","volume":"198","author":"Boucherat","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2020.118009_bb0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10863-016-9670-z","article-title":"The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside","volume":"48","author":"Azevedo-Silva","year":"2016","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.lfs.2020.118009_bb0050","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijcard.2018.03.104","article-title":"3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: in vitro and in vivo studies","volume":"266","author":"Chen","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2020.118009_bb0055","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ajh\/hpy191","article-title":"3-Bromopyruvate attenuates experimental pulmonary hypertension via inhibition of glycolysis","volume":"32","author":"Zhang","year":"2019","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.lfs.2020.118009_bb0060","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1158\/0008-5472.CAN-12-1741","article-title":"Glutamine deprivation enhances antitumor activity of 3-bromopyruvate through the stabilization of monocarboxylate transporter-1","volume":"72","author":"Cardaci","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2020.118009_bb0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/yea.3367","article-title":"3-Bromopyruvate as a potent anticancer therapy in honor and memory of the late Professor Andre Goffeau","volume":"36","author":"Ko","year":"2019","journal-title":"Yeast"},{"key":"10.1016\/j.lfs.2020.118009_bb0070","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1159\/000479401","article-title":"PDGF promotes the Warburg effect in pulmonary arterial smooth muscle cells via activation of the PI3K\/AKT\/mTOR\/HIF-1alpha signaling pathway","volume":"42","author":"Xiao","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2020.118009_bb0075","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/jcmm.12208","article-title":"Apelin inhibits the proliferation and migration of rat PASMCs via the activation of PI3K\/Akt\/mTOR signal and the inhibition of autophagy under hypoxia","volume":"18","author":"Zhang","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2020.118009_bb0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/CAD.0000000000000081","article-title":"3-Bromopyruvate induces apoptosis in breast cancer cells by downregulating Mcl-1 through the PI3K\/Akt signaling pathway","volume":"25","author":"Liu","year":"2014","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.lfs.2020.118009_bb0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/CAD.0000000000000613","article-title":"Synergistic in-vitro effects of combining an antiglycolytic, 3-bromopyruvate, and a bromodomain-4 inhibitor on U937 myeloid leukemia cells","volume":"29","author":"Kapp","year":"2018","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.lfs.2020.118009_bb0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng.2471","article-title":"MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors","volume":"45","author":"Birsoy","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lfs.2020.118009_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pupt.2015.09.007","article-title":"Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: a network approach","volume":"35","author":"Nogueira-Ferreira","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2020.118009_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.phrs.2017.08.003","article-title":"Animal models of pulmonary arterial hypertension: a systematic review and meta-analysis of data from 6126 animals","volume":"125","author":"Sztuka","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2020.118009_bb0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/cvr\/cvv244","article-title":"Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension","volume":"109","author":"Mendes-Ferreira","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2020.118009_bb0110","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/cvr\/cvy076","article-title":"Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension","volume":"114","author":"Adao","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2020.118009_bb0115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.redox.2015.07.016","article-title":"Complex I dysfunction underlies the glycolytic switch in pulmonary hypertensive smooth muscle cells","volume":"6","author":"Rafikov","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2020.118009_bb0120","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/jcmm.13412","article-title":"TPPU enhanced exercise-induced epoxyeicosatrienoic acid concentrations to exert cardioprotection in mice after myocardial infarction","volume":"22","author":"Guo","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2020.118009_bb0125","doi-asserted-by":"crossref","first-page":"L782","DOI":"10.1152\/ajplung.00331.2017","article-title":"Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both","volume":"314","author":"Marshall","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.lfs.2020.118009_bb0130","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/CIRCULATIONAHA.113.004581","article-title":"Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension","volume":"129","author":"Goncharov","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.118009_bb0135","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jacbts.2018.08.009","article-title":"Pathogenic role of mTORC1 and mTORC2 in pulmonary hypertension","volume":"3","author":"Tang","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.lfs.2020.118009_bb0140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1158\/1940-6207.CAPR-14-0142","article-title":"Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro","volume":"8","author":"Zhang","year":"2015","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.lfs.2020.118009_bb0145","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.117.028034","article-title":"Identification of MicroRNA-124 as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension via PTBP1 (polypyrimidine tract binding protein) and pyruvate kinase M2","volume":"136","author":"Caruso","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.118009_bb0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12576-016-0435-6","article-title":"Inhibition of monocarboxylate transporter 1 suppresses the proliferation of glioblastoma stem cells","volume":"66","author":"Takada","year":"2016","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.lfs.2020.118009_bb0155","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1038\/ncomms3935","article-title":"Tumour-associated mutant p53 drives the Warburg effect","volume":"4","author":"Zhang","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2020.118009_bb0160","doi-asserted-by":"crossref","first-page":"L216","DOI":"10.1152\/ajplung.00538.2017","article-title":"Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension","volume":"316","author":"Wang","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.lfs.2020.118009_bb0165","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1038\/onc.2015.360","article-title":"Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters","volume":"35","author":"Gan","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2020.118009_bb0170","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1021\/acsami.7b16685","article-title":"Suppression of tumor energy supply by liposomal nanoparticle-mediated inhibition of aerobic glycolysis","volume":"10","author":"Zhang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.lfs.2020.118009_bb0175","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1158\/1940-6207.CAPR-11-0338","article-title":"Aerosolized 3-bromopyruvate inhibits lung tumorigenesis without causing liver toxicity","volume":"5","author":"Zhang","year":"2012","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.lfs.2020.118009_bb0180","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1590\/s0102-865020160110000004","article-title":"Hepatotoxicity and nephrotoxicity of 3-bromopyruvate in mice","volume":"31","author":"Pan","year":"2016","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.lfs.2020.118009_bb0185","first-page":"356","article-title":"Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study","volume":"33","author":"El Sayed","year":"2014","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118009_bb0190","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1158\/1078-0432.CCR-14-1271","article-title":"Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer","volume":"20","author":"Chapiro","year":"2014","journal-title":"Clin. Cancer Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520307591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520307591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T19:21:10Z","timestamp":1735413670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520307591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":38,"alternative-id":["S0024320520307591"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118009","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3-Bromopyruvate ameliorates pulmonary arterial hypertension by improving mitochondrial metabolism","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118009"}}